NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying essential chemical components that drive innovation in advanced synthesis. Among our key offerings is 1,3-Bis(4-hydroxybutyl)tetramethyldisiloxane, identified by CAS number 5931-17-9. This organosilicon compound is a prime example of a tetramethyldisiloxane derivative that plays a pivotal role in modern chemical synthesis, particularly in the realm of polymer science.

The molecular structure of 1,3-Bis(4-hydroxybutyl)tetramethyldisiloxane, represented by C12H30O3Si2, features hydroxyl-terminated butyl chains attached to a stable disiloxane core. This specific arrangement makes it an exceptionally effective organosilicon end-capper. In polymerization processes, such as those used to create specialized silicones, this compound acts to precisely terminate polymer chain growth. This control is fundamental for achieving polymers with targeted molecular weights and desired physical characteristics, a crucial aspect of advanced material development.

The synthesis of high purity siloxane compounds like this is a complex endeavor, and NINGBO INNO PHARMCHEM CO.,LTD. has honed its expertise in this area. By ensuring the consistent quality and availability of this chemical intermediate, we enable researchers and manufacturers to push the boundaries of innovation. The applications for such precisely engineered molecules are vast, spanning from advanced medical materials to specialized industrial formulations, all of which benefit from the controlled properties imparted by these derivatives.

For any organization engaged in cutting-edge chemical synthesis or material science research, understanding and sourcing key intermediates like 1,3-bis(4-hydroxybutyl)tetramethyldisiloxane is essential. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to being a reliable partner, providing not only the necessary chemicals but also the expertise to support your most ambitious projects. Our commitment to quality and innovation ensures that you have the building blocks for future material breakthroughs.